Patricia L Marion

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication
    Patricia L Marion
    Division of Gastroenterology, Stanford University School of Medicine, Stanford, California 94305 5187, USA
    Antimicrob Agents Chemother 46:82-8. 2002
  2. ncbi In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus
    Bruno B Bordier
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California 94305, USA
    J Clin Invest 112:407-14. 2003
  3. ncbi Inhibition of hepatitis B virus in mice by RNA interference
    Anton P McCaffrey
    Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room G305, Stanford, California, USA
    Nat Biotechnol 21:639-44. 2003
  4. ncbi A prenylation inhibitor prevents production of infectious hepatitis delta virus particles
    Bruno B Bordier
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 269 Campus Drive, Palo Alto, CA 94305-5187, USA
    J Virol 76:10465-72. 2002
  5. ncbi Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection
    Wendy K Foster
    School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia 5005, Australia
    Antimicrob Agents Chemother 47:2624-35. 2003
  6. ncbi Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice
    Christina Rauschhuber
    Max von Pettenkofer Institute, Department of Virology, Ludwig Maximilians Universitat Munchen, Munich, Germany
    J Gene Med 10:878-89. 2008

Collaborators

Detail Information

Publications6

  1. ncbi Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication
    Patricia L Marion
    Division of Gastroenterology, Stanford University School of Medicine, Stanford, California 94305 5187, USA
    Antimicrob Agents Chemother 46:82-8. 2002
    ..ETV and 3TC were both well tolerated in all treated animals. These results show that ETV is a highly potent and effective antiviral in the DHBV duck model...
  2. ncbi In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus
    Bruno B Bordier
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California 94305, USA
    J Clin Invest 112:407-14. 2003
    ..These results provide the first preclinical data supporting the in vivo efficacy of prenylation inhibition as a novel antiviral therapy with potential application to HDV and a wide variety of other viruses...
  3. ncbi Inhibition of hepatitis B virus in mice by RNA interference
    Anton P McCaffrey
    Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room G305, Stanford, California, USA
    Nat Biotechnol 21:639-44. 2003
    ..Thus, RNAi effectively inhibited replication initiation in cultured cells and mammalian liver, showing that such an approach could be useful in the treatment of viral diseases...
  4. ncbi A prenylation inhibitor prevents production of infectious hepatitis delta virus particles
    Bruno B Bordier
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 269 Campus Drive, Palo Alto, CA 94305-5187, USA
    J Virol 76:10465-72. 2002
    ..Farnesyltransferase inhibitors thus represent an attractive potential class of novel antiviral agents for use against HDV, including the genotypes associated with most severe disease...
  5. ncbi Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection
    Wendy K Foster
    School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia 5005, Australia
    Antimicrob Agents Chemother 47:2624-35. 2003
    ....
  6. ncbi Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice
    Christina Rauschhuber
    Max von Pettenkofer Institute, Department of Virology, Ludwig Maximilians Universitat Munchen, Munich, Germany
    J Gene Med 10:878-89. 2008
    ..2, which was demonstrated to result in post-transcriptional knock-down of HBV transcripts...